Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.